6550--Cepheid GeneXpert Testing Supplies

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

245-NETWORK CONTRACT OFFICE 5 (36C245)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C24526R0114

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Classification Code

6550

Additional Details
Set Aside

None

Place of Performance

VAMHCS, Washington VAMC

SourceSAM
Documents1
The Department of Veterans Affairs (VA), through its Network Contract Office 5 (NCO 5), has announced its intent to solicit proposals for the provision of Cepheid GeneXpert Testing Supplies to support six VA Medical Centers (VAMCs) across West Virginia, Maryland, and Washington, DC. This procurement, identified under RFP number 36C24526R0114, is being issued as an unrestricted opportunity, inviting participation from all qualified vendors. The primary objective of this procurement is to ensure a reliable and consistent supply of Cepheid GeneXpert testing materials, which are critical for in-vitro diagnostic applications within the VA healthcare system. The anticipated contract will be structured as a single-award, firm-fixed price Indefinite Delivery-Indefinite Quantity (IDIQ) agreement, encompassing a base year with the possibility of four additional option years. This structure is designed to provide flexibility in meeting the evolving needs of the supported medical centers while maintaining cost predictability and contractual stability. The six VA facilities to be supported under this contract include: - Beckley VAMC, Beckley, WV - Martinsburg VAMC, Martinsburg, WV - VA Maryland Health Care System, Baltimore, MD - Washington DC VAMC, Washington, DC - Louis A. Johnson VAMC, Clarksburg, WV - Huntington VAMC, Huntington, WV Delivery orders will be issued on a firm-fixed price basis for each facility, contingent upon the availability of funds for both the base and option years. The scope of work, including detailed requirements and deliverables, will be outlined in the formal solicitation and accompanying statement of work, which is expected to be released on or about October 7, 2026, via the official contract opportunities portal at SAM.gov. The applicable North American Industry Classification System (NAICS) code for this procurement is 325413, which pertains to In-Vitro Diagnostic Substance Manufacturing. The corresponding Product Service Code (PSC) is 6550, further specifying the focus on medical and surgical instruments, equipment, and supplies. Interested contractors should note that this is a federal procurement with no set-aside restrictions, allowing for broad competition. All prospective offerors must be registered in the System for Award Management (SAM) at https://sam.gov prior to submitting a proposal. The contracting activity is managed by the 245-Network Contract Office 5, with Michael Jones serving as the primary point of contact. He can be reached at [email protected] or by phone at (202) 745-8000 Ext. 58768 for any inquiries related to this opportunity. The formal solicitation will provide comprehensive instructions regarding proposal submission, evaluation criteria, and contract terms. Contractors are encouraged to monitor the SAM.gov listing (Opportunity ID: ae9e6c6f10ea4b25967b54605b3d3a0b) for updates, attachments, and official documentation as it becomes available. The response deadline for proposals is currently set for November 16, 2026. This procurement represents a significant opportunity for suppliers specializing in in-vitro diagnostic substances, particularly those with experience supporting large, multi-site healthcare systems. The long-term, IDIQ nature of the contract and the critical role of GeneXpert testing in VA medical operations underscore the importance of reliability, quality, and responsive service from the selected contractor.